The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Transnetyx Inc, 8110 Cordova Rd. Suite 119, Cordova, TN, 38016, USA.
BMC Biol. 2024 Feb 2;22(1):26. doi: 10.1186/s12915-024-01834-z.
The ability of recombinant adeno-associated virus to transduce preimplantation mouse embryos has led to the use of this delivery method for the production of genetically altered knock-in mice via CRISPR-Cas9. The potential exists for this method to simplify the production and extend the types of alleles that can be generated directly in the zygote, obviating the need for manipulations of the mouse genome via the embryonic stem cell route.
We present the production data from a total of 13 genetically altered knock-in mouse models generated using CRISPR-Cas9 electroporation of zygotes and delivery of donor repair templates via transduction with recombinant adeno-associated virus. We explore the efficiency of gene targeting at a total of 12 independent genetic loci and explore the effects of allele complexity and introduce strategies for efficient identification of founder animals. In addition, we investigate the reliability of germline transmission of the engineered allele from founder mice generated using this methodology. By comparing our production data against genetically altered knock-in mice generated via gene targeting in embryonic stem cells and their microinjection into blastocysts, we assess the animal cost of the two methods.
Our results confirm that recombinant adeno-associated virus transduction of zygotes provides a robust and effective delivery route for donor templates for the production of knock-in mice, across a range of insertion sizes (0.9-4.7 kb). We find that the animal cost of this method is considerably less than generating knock-in models via embryonic stem cells and thus constitutes a considerable 3Rs reduction.
重组腺相关病毒能够转导着床前的小鼠胚胎,这使得该传递方法可用于通过 CRISPR-Cas9 产生基因修饰的敲入小鼠。这种方法有可能简化生产过程,并扩展可在受精卵中直接产生的等位基因类型,从而避免通过胚胎干细胞途径对小鼠基因组进行操作。
我们展示了总共 13 种使用 CRISPR-Cas9 电穿孔受精卵和通过重组腺相关病毒转导供体修复模板生成的基因修饰敲入小鼠模型的生产数据。我们在总共 12 个独立的遗传基因座上探索了基因靶向的效率,并研究了等位基因复杂性的影响,并提出了有效鉴定供体动物的策略。此外,我们还研究了从使用这种方法生成的供体小鼠中工程化等位基因在生殖系中的传递可靠性。通过将我们的生产数据与通过胚胎干细胞中的基因靶向和微注射到囊胚中生成的基因修饰敲入小鼠进行比较,我们评估了两种方法的动物成本。
我们的结果证实,重组腺相关病毒转导受精卵为生产敲入小鼠提供了一种强大而有效的供体模板传递途径,适用于多种插入大小(0.9-4.7 kb)。我们发现,这种方法的动物成本明显低于通过胚胎干细胞生成敲入模型,因此构成了相当大的 3R 减少。